Cargando…
Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population
A combination of long-acting anticholinergic agents (LAACs) and long-acting β(2)-adrenergic receptor agonist (LABA) is effective in improving lung function in chronic obstructive pulmonary disease (COPD) compared with monotherapy. However, evidence on whether this combination increases the incidence...
Autores principales: | Tsai, Ming-Jun, Chen, Chung-Yu, Huang, Yaw-Bin, Chao, Hsiao-Chung, Yang, Chih-Jen, Lin, Pei-Jin, Tsai, Yi-Hung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697980/ https://www.ncbi.nlm.nih.gov/pubmed/26705214 http://dx.doi.org/10.1097/MD.0000000000002306 |
Ejemplares similares
-
Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population: Erratum
Publicado: (2016) -
Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study
por: Lee, Ming-Chia, et al.
Publicado: (2015) -
Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease
por: Liao, Kuang-Ming, et al.
Publicado: (2015) -
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
por: Wang, Meng-Ting, et al.
Publicado: (2019) -
Use of fractional exhaled nitric oxide as a potential predictor of bronchodilator response
por: Provenzano, Bruna Cuoco, et al.
Publicado: (2023)